Filing Details

Accession Number:
0001415889-24-010059
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-04-03 17:00:11
Reporting Period:
2024-04-01
Accepted Time:
2024-04-03 17:00:11
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1211583 Fennec Pharmaceuticals Inc. FENC Biological Products, (No Disgnostic Substances) (2836) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1468308 Robert Andrade C/O Fennec Pharmaceuticals, Inc.
Po Box 13628, 68 Tw Alexander Drive
Research Triangle Park NC 27709
Chief Financial Officer No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Shares Acquisiton 2024-04-01 12,500 $0.00 104,271 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Footnotes
  1. Represents release of restriction from shares awarded 3-31-2023.